Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780)
01/2013
01/01/2013US8344159 Carvedilol phosphate sesquihydrate
01/01/2013US8344017 Anti-hepatitis C virus agents and anti-HIV agents
01/01/2013US8343986 Matrix metalloproteinase inhibitors
01/01/2013US8343964 Indolic derivatives, their preparation processes and their uses in particular as antibacterials
12/2012
12/27/2012WO2012178142A1 Ppar-sparing compounds and combinations fort the treatment of diabetes and other metabolic diseases
12/27/2012WO2012177618A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
12/27/2012WO2012176818A1 Organic electroluminescent element
12/27/2012WO2012174926A1 N-substituted isopropyldimethyl azulene sulfonamide derivatives, and preparation method and use thereof
12/27/2012US20120330030 Enantioselective Synthesis of y-amino-a, B-unsuturated carboxylic acid derivatives
12/27/2012US20120330008 Novel process for the preparation of bazedoxifene acetate and intermediates thereof
12/27/2012US20120329846 Therapeutic agent for inflammatory bowel disease and tnf-alpha production inhibitor
12/27/2012US20120329649 Pesticidal compositions and processes related thereto
12/27/2012US20120328985 Fluorine-Containing Sulfonate Resin, Fluorine-Containing N-Sulfonyloxyimide Resin, Resist Composition and Pattern Formation Method
12/27/2012US20120328514 N-alkoxyamide conjugates as imaging agents
12/27/2012CA2839956A1 Prostaglandin receptor ep2 antagonists, derivatives, compositions, and uses related thereto
12/26/2012EP2536709A2 Prolylhydroxylase inhibitors and methods of use
12/26/2012CN1826333B Diamine derivatives
12/26/2012CN102838609A Azabicyclo [3.3.0] octane derivative, as well as preparation method and application thereof
12/26/2012CN102838526A Preparation method of chiral Beta-indolyl-Gamma-aldehyde group nitro alkanes
12/26/2012CN102838525A Synthesis method of 1-amyl-3-(1naphthoyl) indole
12/26/2012CN102838524A Method for preparing 5-halogen-2, 3-diphenylindole
12/26/2012CN102838492A Novel compound and organic light-emitting device including the same
12/26/2012CN102838443A Hexafluorenylbenzene derivative and application thereof to organic photoelectric functional material
12/26/2012CN102838442A 9-alkenylfluorene derivatives and application thereof
12/26/2012CN102584678B Synthesis method of N-phenyl-3(4-bromophenyl) carbazole
12/26/2012CN102153502B Carbazole derivative and light-emitting element and light-emitting apparatus using carbazole derivative
12/26/2012CN101730703B Benzamide derivatives with anti-proliferative activity, pharmaceutical preparations thereof
12/26/2012CN101608114B Macromolecular iridium complex electroluminescent phosphor material and synthesis method thereof
12/26/2012CN101128425B Dimeric IAP inhibitors
12/26/2012CN101077972B Organic light-emitting compound and organic electroluminescent device using the same
12/25/2012US8338696 Benzoindole-based compound and dye-sensitized solar cell using the same
12/25/2012US8338590 Substituted oxindole derivatives and medicaments containing the same
12/25/2012US8338474 Use of phthalimide and/or sulphonamide derivatives in the treatment of diseases which require reducing the TNF-α levels and an exogenous source of nitric oxide, phthalimide derivatives, sulphonamide derivatives, and a method for obtaining a sulphonamide derivative
12/25/2012US8338473 Derivatives of psammaplin A, a method for their synthesis and their uses for the prevention or treatment of cancer
12/25/2012US8338422 Indolin-2-ones and aza-indolin-2-ones
12/25/2012US8338416 Indole derivatives as inhibitors of histone deacetylase
12/25/2012US8338081 Alkali-developable photosensitive resin composition and β-diketone compound
12/25/2012US8338000 Organic light emitting device
12/20/2012WO2012173073A1 Light emitting element material and light emitting element
12/20/2012WO2012147107A3 Novel & improved processes for preparing indoline derivatives and its pharmaceutical composition
12/20/2012WO2012110833A3 Fluorescence modulators
12/20/2012US20120322906 Polymer and methods of preparing and using a polymer
12/20/2012US20120322808 Alpha 4 Beta 2 NEURONAL NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS
12/20/2012US20120322800 Sepiapterin Reductase Inhibitors For The Treatment of Pain
12/20/2012US20120322769 Methods of reducing virulence in bacteria
12/20/2012US20120321613 Molecular targets for healing or treating wounds
12/20/2012US20120318348 Organic photovoltaic-battery hybrid device
12/19/2012CN102834379A Tricyclic indole derivatives as PBR ligands
12/19/2012CN102832349A Light-emitting element, light-emitting device, ad electronic device
12/19/2012CN102827246A Large cyclic heterocyclic compound for inhibiting hepatitis C virus as well as preparation and application thereof
12/19/2012CN102827066A Indenocarbazole derivatives and preparation method thereof
12/19/2012CN102827065A Preparation method for N-phenyl-3-bromocarbazole
12/19/2012CN102827064A Synthetic method for aza-bicyclo octane[3.3.0] derivatives
12/19/2012CN102827063A Synthetic method for aza-bicyclo octane[3.3.0] derivatives
12/19/2012CN102827062A Method for preparing almotriptan malate
12/19/2012CN102827061A 5,6,7- trimethoxy indole derivative, preparation method and use thereof
12/19/2012CN102826946A Green synthesis process of aryl methyl low-carbonate
12/19/2012CN101823965B Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof
12/19/2012CN101790514B 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof
12/18/2012US8334316 Substituted organosulfur compounds and methods of using thereof
12/18/2012US8334300 C2-phenyl-substituted cyclic ketonols
12/18/2012CA2671776C Gal3 receptor antagonists for the treatment of depression
12/18/2012CA2511214C Asthma and allergic inflammation modulators
12/13/2012WO2012170561A1 N-benzylindole modulators of pparg
12/13/2012WO2012170554A1 N-biphenylmethylindole modulators of pparg
12/13/2012WO2012169661A1 Monatin polyvalent metal salt crystal
12/13/2012WO2012169575A1 Method for manufacturing optically active carboxylic acid ester
12/13/2012WO2012168664A1 4-{3-[trans-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide, method for preparing same and pharmaceutical compositions that contain same
12/13/2012WO2012168657A1 Process for synthesis and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide hydrochloride, in addition to the associated free base and the pharmaceutical compositions containing same
12/13/2012US20120316214 Synthesis process, and crystalline form of 4-benzamide hydrochloride and pharmaceutical compositions containing it
12/13/2012US20120316171 Tryptophan Hydroxylase Inhibitors for the Treatment of Cancer
12/12/2012EP2532660A1 Synthetic intermediates prepared using a 2-deoxyribose-5-phosphate aldolase (DERA) chemoenzymatic process
12/12/2012EP2532651A1 Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1h)-yl]propoxy}benzamide hydrochloride and its free base as well as the pharmaceutical compositions containing them
12/12/2012EP2532650A2 Modulators of ATP-binding cassette transporters
12/12/2012EP2531488A2 Indirubin-3'-oxime derivatives as potent cyclin dependent kinase inhibitors
12/12/2012EP2531029A1 Selective androgen receptor modulators
12/12/2012CN102822147A Process for the preparation of alpha-acyloxy beta-formamido amides
12/12/2012CN102816114A Preparation method of HMG-CoA reductase inhibitor
12/12/2012CN102816107A Carbazole derivative and preparation method and use thereof
12/12/2012CN102816106A Biocatalytic processes for the preparation of substantially stereomerically pure fused bicyclic proline compounds
12/12/2012CN102816105A Azabicyclo[4.3.0]nonenoyl halide intermediate, its preparation method and application
12/12/2012CN102816104A 3-cyanoindole compound synthesis method
12/12/2012CN102816103A Vulcanized aspartic acid modified melatonin derivative and application thereof
12/12/2012CN102816102A Synthesis process, and crystalline form of 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy} benzamide hydrochloride and pharmaceutical compositions containing it
12/12/2012CN102816078A Preparation method of N-(5-methoxycarbonyl-2-hydroxyphenyl) amino acid ester compounds
12/12/2012CN102311544B Rosinyl plasticizer and preparation method thereof
12/12/2012CN102212027B Preparation method for sumatriptan
12/12/2012CN102030696B Method for synthesizing tryptophol compound under catalysis of sulfonated MCM-41 (Mobile Crystalline Material-41)
12/12/2012CN101786935B Method for extracting fluorene, anthracene and carbazole from mixed anthracene oil
12/11/2012US8329751 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
12/11/2012US8329740 Polymorphs of sunitinib malate
12/11/2012US8329718 N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
12/11/2012US8329689 Substituted indoles and a method for the production and use thereof
12/11/2012US8329377 Imide compound and chemically amplified resist composition containing the same
12/11/2012US8328879 Phthalimides as bleach activators
12/11/2012CA2562539C Substituted cyclohexylcarboxylic acid derivatives
12/11/2012CA2535704C Aminopropanol derivatives
12/11/2012CA2515780C Phenylenediamine urotensin-ii receptor antagonists and ccr-9 antagonists
12/08/2012CA2779045A1 Synthesis process and crystalline form of benzamide 4-{3-¬cis-hexahydrocyclopenta¬c|pyrrol-2(1h)-yl|propoxy} hydrochloride as well as the pharmaceutical compositions in which it is found
12/06/2012WO2012165981A1 Novel hybrid cholinesterase inhibitors
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 458